4065 studies found for:    Japan
Show Display Options
Rank Status Study
1 Recruiting A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection
Conditions: Chronic Hepatitis C Virus;   Hepatitis C Virus
Interventions: Drug: ABT-493/ABT-530;   Drug: Sofosbuvir;   Drug: Ribavirin
2 Recruiting A Phase 2b/3, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Japanese Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: ABT-494;   Drug: Placebo
3 Recruiting A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection
Conditions: Chronic Hepatitis C Virus;   Hepatitis C Virus
Interventions: Drug: ABT-493/ABT-530;   Drug: Ombitasvir/paritaprevir/ritonavir
4 Recruiting BI 655066 Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: BI 655066;   Drug: placebo to ustekinumab;   Drug: ustekinumab;   Drug: placebo to BI 655066
5 Not yet recruiting Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
Condition: Osteoarthritis
Intervention: Drug: Investigational Medical Product (IMP) administered in parent study
6 Recruiting Long-Term Specified Drug Use-Results Survey for Xtandi Capsule
Condition: Castration-resistant Prostate Cancer
Intervention: Drug: Xtandi
7 Recruiting Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer).
Condition: Brain Neoplasms
Interventions: Drug: Nivolumab;   Drug: Temozolomide;   Radiation: Radiotherapy;   Other: Nivolumab Placebo
8 Active, not recruiting Zenith® TXD Post-market Surveillance in Japan
Condition: Aortic Dissection
Intervention: Device: Zenith® TXD
9 Recruiting A Phase 3 Study to Evaluate the Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids
Condition: Uterine Fibroids
Interventions: Drug: TAK-385 40 mg;   Drug: Leuprorelin 1.88 mg;   Drug: Leuprorelin 3.75 mg
10 Recruiting An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis
Condition: Palmoplantar Pustulosis
Interventions: Drug: Guselkumab;   Drug: Placebo
11 Recruiting Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
Condition: Asthma
Intervention:
12 Recruiting A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention
Condition: Migraine
Interventions: Drug: AMG 334 Dose Level 1;   Drug: Placebo;   Drug: AMG 334 Dose Level 2;   Drug: AMG 334 Dose Level 3
13 Recruiting Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium;   Drug: olodaterol
14 Recruiting Study of Nivolumab Versus Temozolomide, Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Condition: Brain Cancer
Interventions: Drug: Nivolumab;   Drug: Temozolomide;   Radiation: Radiotherapy
15 Recruiting Special Drug Use Surveillance of Irribow in Female Patients
Condition: Diarrhea-predominant Irritable Bowel Syndrome
Intervention: Drug: Ramosetron
16 Recruiting All-Case Surveillance of Ofev in Patients With IPF in Japan
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Nintedanib
17 Recruiting A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
Condition: Scleroderma, Systemic
Interventions: Drug: Nintedanib;   Drug: Placebo
18 Recruiting Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection
Condition: Hepatitis C
Intervention: Drug: Harvoni
19 Recruiting Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Empagliflozin;   Drug: Placebo
20 Recruiting The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With Type 1 Diabetes Mellitus (T1DM)
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Dapagliflozin 5 mg;   Drug: Dapagliflozin 10mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years